179 related articles for article (PubMed ID: 2452480)
1. Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells.
Mitsuya H; Looney DJ; Kuno S; Ueno R; Wong-Staal F; Broder S
Science; 1988 Apr; 240(4852):646-9. PubMed ID: 2452480
[TBL] [Abstract][Full Text] [Related]
2. Dextran sulfate as an inhibitor against the human immunodeficiency virus.
Chang RS; Tabba HD; He YS; Smith KM
Proc Soc Exp Biol Med; 1988 Dec; 189(3):304-9. PubMed ID: 2462737
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric method to demonstrate whether anti-HIV-1 agents inhibit virion binding to T4+ cells.
Schols D; Baba M; Pauwels R; De Clercq E
J Acquir Immune Defic Syndr (1988); 1989; 2(1):10-5. PubMed ID: 2465402
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.
Mitsuya H; Broder S
AIDS Res Hum Retroviruses; 1988 Apr; 4(2):107-13. PubMed ID: 2835072
[TBL] [Abstract][Full Text] [Related]
5. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.
Lederman S; Gulick R; Chess L
J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782
[TBL] [Abstract][Full Text] [Related]
6. Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1.
Richman DD
Antimicrob Agents Chemother; 1987 Dec; 31(12):1879-81. PubMed ID: 3501941
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.
Baba M; Pauwels R; Balzarini J; Arnout J; Desmyter J; De Clercq E
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6132-6. PubMed ID: 2457906
[TBL] [Abstract][Full Text] [Related]
8. Dextran sulphate, a potent anti-HIV agent in vitro having synergism with zidovudine.
Ueno R; Kuno S
Lancet; 1987 Jun; 1(8546):1379. PubMed ID: 2438524
[No Abstract] [Full Text] [Related]
9. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
Traunecker A; Lüke W; Karjalainen K
Nature; 1988 Jan; 331(6151):84-6. PubMed ID: 2829024
[TBL] [Abstract][Full Text] [Related]
10. Effect of pH on giant cell formation induced by human immunodeficiency virus ( HIV ).
Yoshiyama H; Kajii T; Yamamoto N; Kobayashi N
Biochem Biophys Res Commun; 1989 Feb; 158(3):973-9. PubMed ID: 2537642
[TBL] [Abstract][Full Text] [Related]
11. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles.
Sato H; Orenstein J; Dimitrov D; Martin M
Virology; 1992 Feb; 186(2):712-24. PubMed ID: 1370739
[TBL] [Abstract][Full Text] [Related]
12. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.
Schols D; Pauwels R; Desmyter J; De Clercq E
Virology; 1990 Apr; 175(2):556-61. PubMed ID: 1691563
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.
Farrar WL; Harel-Bellan A; Ferris DK
Crit Rev Immunol; 1988; 8(4):315-39. PubMed ID: 2850890
[TBL] [Abstract][Full Text] [Related]
14. Identification of the fusion peptide of primate immunodeficiency viruses.
Bosch ML; Earl PL; Fargnoli K; Picciafuoco S; Giombini F; Wong-Staal F; Franchini G
Science; 1989 May; 244(4905):694-7. PubMed ID: 2541505
[TBL] [Abstract][Full Text] [Related]
15. Anti-HIV synergy between dextran sulphate and zidovudine.
Berenbaum MC
Lancet; 1987 Aug; 2(8556):461. PubMed ID: 2442572
[No Abstract] [Full Text] [Related]
16. CD4+ lymphocyte function with early human immunodeficiency virus infection.
Gurley RJ; Ikeuchi K; Byrn RA; Anderson K; Groopman JE
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1993-7. PubMed ID: 2564677
[TBL] [Abstract][Full Text] [Related]
17. Anti-HIV synergism between dextran sulphate and zidovudine.
Ueno R; Kuno S
Lancet; 1987 Oct; 2(8562):796-7. PubMed ID: 2443775
[No Abstract] [Full Text] [Related]
18. Implications of the discovery of HTLV-III for the treatment of AIDS.
Yarchoan R; Mitsuya H; Matsushita S; Broder S
Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
[TBL] [Abstract][Full Text] [Related]
19. Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein.
Jameson BA; Rao PE; Kong LI; Hahn BH; Shaw GM; Hood LE; Kent SB
Science; 1988 Jun; 240(4857):1335-9. PubMed ID: 2453925
[TBL] [Abstract][Full Text] [Related]
20. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor.
Schols D; Baba M; Pauwels R; Desmyter J; De Clercq E
Proc Natl Acad Sci U S A; 1989 May; 86(9):3322-6. PubMed ID: 2566170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
